523 related articles for article (PubMed ID: 16285941)
1. Unexpected role of surface transglutaminase type II in celiac disease.
Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
[TBL] [Abstract][Full Text] [Related]
2. Transglutaminase 2 in celiac disease: minireview article.
Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
[TBL] [Abstract][Full Text] [Related]
3. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
Lindfors K; Mäki M; Kaukinen K
Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
[TBL] [Abstract][Full Text] [Related]
4. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits.
Stenman SM; Lindfors K; Korponay-Szabo IR; Lohi O; Saavalainen P; Partanen J; Haimila K; Wieser H; Mäki M; Kaukinen K
BMC Immunol; 2008 Feb; 9():6. PubMed ID: 18312620
[TBL] [Abstract][Full Text] [Related]
5. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
[TBL] [Abstract][Full Text] [Related]
6. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
Korponay-Szabó IR; Vecsei Z; Király R; Dahlbom I; Chirdo F; Nemes E; Fésüs L; Mäki M
J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy.
Tosco A; Maglio M; Paparo F; Rapacciuolo L; Sannino A; Miele E; Barone MV; Auricchio R; Troncone R
J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):293-8. PubMed ID: 18728524
[TBL] [Abstract][Full Text] [Related]
8. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies from patients with celiac disease inhibit transglutaminase 2 binding to heparin/heparan sulfate and interfere with intestinal epithelial cell adhesion.
Teesalu K; Panarina M; Uibo O; Uibo R; Utt M
Amino Acids; 2012 Feb; 42(2-3):1055-64. PubMed ID: 21847613
[TBL] [Abstract][Full Text] [Related]
10. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.
Gianfrani C; Siciliano RA; Facchiano AM; Camarca A; Mazzeo MF; Costantini S; Salvati VM; Maurano F; Mazzarella G; Iaquinto G; Bergamo P; Rossi M
Gastroenterology; 2007 Sep; 133(3):780-9. PubMed ID: 17678925
[TBL] [Abstract][Full Text] [Related]
11. Early developing celiac disease in children with cerebral palsy.
Stenberg R; Kaukinen K; Bengtsson M; Lindberg E; Dahle C
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):674-8. PubMed ID: 21697743
[TBL] [Abstract][Full Text] [Related]
12. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
13. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
Molberg O; McAdam S; Lundin KE; Kristiansen C; Arentz-Hansen H; Kett K; Sollid LM
Eur J Immunol; 2001 May; 31(5):1317-23. PubMed ID: 11465088
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal accumulation of gliadin p31-43 peptide induces oxidative stress and tissue transglutaminase-mediated PPARgamma downregulation in intestinal epithelial cells and coeliac mucosa.
Luciani A; Villella VR; Vasaturo A; Giardino I; Pettoello-Mantovani M; Guido S; Cexus ON; Peake N; Londei M; Quaratino S; Maiuri L
Gut; 2010 Mar; 59(3):311-9. PubMed ID: 19951908
[TBL] [Abstract][Full Text] [Related]
15. Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease.
Tosco A; Aitoro R; Auricchio R; Ponticelli D; Miele E; Paparo F; Greco L; Troncone R; Maglio M
Clin Exp Immunol; 2013 Jan; 171(1):69-75. PubMed ID: 23199325
[TBL] [Abstract][Full Text] [Related]
16. Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.
Rauhavirta T; Oittinen M; Kivistö R; Männistö PT; Garcia-Horsman JA; Wang Z; Griffin M; Mäki M; Kaukinen K; Lindfors K
J Clin Immunol; 2013 Jan; 33(1):134-42. PubMed ID: 22878839
[TBL] [Abstract][Full Text] [Related]
17. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits.
Salmi TT; Collin P; Korponay-Szabó IR; Laurila K; Partanen J; Huhtala H; Király R; Lorand L; Reunala T; Mäki M; Kaukinen K
Gut; 2006 Dec; 55(12):1746-53. PubMed ID: 16571636
[TBL] [Abstract][Full Text] [Related]
18. Characterization of IL-17A-producing cells in celiac disease mucosa.
Monteleone I; Sarra M; Del Vecchio Blanco G; Paoluzi OA; Franzè E; Fina D; Fabrizi A; MacDonald TT; Pallone F; Monteleone G
J Immunol; 2010 Feb; 184(4):2211-8. PubMed ID: 20061410
[TBL] [Abstract][Full Text] [Related]
19. Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.
Lebreton C; Ménard S; Abed J; Moura IC; Coppo R; Dugave C; Monteiro RC; Fricot A; Traore MG; Griffin M; Cellier C; Malamut G; Cerf-Bensussan N; Heyman M
Gastroenterology; 2012 Sep; 143(3):698-707.e4. PubMed ID: 22750506
[TBL] [Abstract][Full Text] [Related]
20. Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease.
Tosco A; Auricchio R; Aitoro R; Ponticelli D; Primario M; Miele E; Rotondi Aufiero V; Discepolo V; Greco L; Troncone R; Maglio M
Clin Exp Immunol; 2014 Sep; 177(3):611-7. PubMed ID: 24773630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]